Samsung Medical Center
| Corea del Sur | España | Turquía | |
| Quimioterapia para el cáncer de mama | de $19,200 | de $3,500 | de $1,200 |
| Crioterapia | de $6,800 | de $5,000 | de $250 |
| Ablación por ultrasonido focalizado de alta intensidad (HIFU) | de $12,500 | de $6,000 | de $4,000 |
| Radioterapia para el cáncer colorrectal | - | de $10,000 | de $7,000 |
| Quimioterapia intraarterial | - | de $20,000 | de $15,000 |
Bookimed no añade cargos extra a los precios de los tratamientos de Retinoblastoma. Las tarifas proceden de las listas de precios oficiales de las clínicas. Pagará directamente en la clínica por su tratamiento a su llegada al país.
Bookimed está comprometido con su seguridad. Solo trabajamos con las clínicas que mantienen altos estándares internacionales en el tratamiento de Retinoblastoma y cuentan con las licencias necesarias para atender a pacientes internacionales en todo el mundo.
Bookimed ofrece asistencia experta gratuita. Un coordinador médico personal le apoya antes, durante y después de su tratamiento, resolviendo cualquier problema. Nunca estará solo en su viaje médico de tratamiento de Retinoblastoma.
Top Korean hospitals for retinoblastoma include Samsung Medical Center, Seoul National University Bundang Hospital, and Severance Hospital. These Seoul-based tertiary centers utilize image-guided radiation therapy and cryotherapy. They provide essential multidisciplinary care. JCI and KOIHA accreditations ensure high safety standards for international pediatric oncology patients.
Bookimed Expert Insight: Retinoblastoma cases in Korea are concentrated in large academic centers like Severance and Samsung. These facilities handle massive patient volumes, with Severance seeing 4,000,000 outpatients annually. This high frequency allows surgeons to maintain specialized skill sets specifically for rare pediatric eye cancers. You should choose these high-volume centers to ensure the ophthalmology and oncology teams work together daily.
Patient Consensus: Patients emphasize finding a hospital that can provide rapid diagnostic imaging and same-week evaluation. They note that having pediatric anesthesia and oncology in one system is vital for young children.
Modern retinoblastoma treatment in South Korea utilizes advanced eye-saving protocols like intra-arterial chemotherapy and cryotherapy. JCI-accredited centers in Seoul prioritize preserving vision through multidisciplinary care. Specialized ocular oncology teams employ high-intensity focused ultrasound ablation and laser therapies to target tumors while minimizing systemic toxicity.
Bookimed Expert Insight: Clinical data from Seoul's major medical complexes reveals a massive focus on high-volume oncology expertise. Severance Hospital alone serves over 4,000,000 patients annually. This massive scale allows Korean teams to maintain specialized pediatric ocular oncology units that are rare in smaller medical markets.
Patient Consensus: Patients note that choosing a center with a dedicated pediatric team is vital. Many emphasize that intra-arterial and intravitreal chemotherapy are the most sought-after options for preventing eye removal.
South Korean university hospitals house specialized multidisciplinary teams for pediatric eye cancer. These centers combine pediatric oncology and ophthalmology to treat retinoblastoma. Top facilities like Samsung Medical Center and Severance Hospital utilize advanced technologies like Novalis and image-guided radiation therapy to preserve vision.
Bookimed Expert Insight: Retinoblastoma care in Korea is concentrated in high-volume academic centers rather than small clinics. Severance Hospital alone manages 4 million outpatients annually. This massive scale allows major university hospitals to maintain dedicated retinoblastoma pathways. These pathways ensure pediatric anesthesia, imaging, and oncology coordination happen in one building. This centralized approach is why Korea maintains a global rank of 4 for medical requests.
Patient Consensus: Parents find that major university hospitals are the only centers equipped for complex pediatric anesthesia during eye scans. They advise choosing a facility that has a specific team for eye tumors rather than just a general ophthalmology department.
Korean oncology centers report high survival rates for retinoblastoma, reaching approximately 93.9% over 10 years. Specialized centers focus on advanced globe-salvage techniques like intra-arterial chemotherapy. These methods successfully preserve the eye in nearly 50% of primary cases and 75% when combined with radiotherapy.
Bookimed Expert Insight: Korea's clinical strength lies in its digital-first infrastructure. For example, Seoul National University Bundang Hospital uses the BESTcare system to minimize medical errors. This technological layer ensures that complex pediatric dosages for chemotherapy are highly precise, which directly supports the country's superior safety record in life salvage compared to other Asian regions.
Patient Consensus: Parents emphasize that while cancer control is often successful, visual recovery is not guaranteed. They recommend choosing multidisciplinary teams involving both pediatric oncologists and ophthalmologists to manage the intensive follow-up schedule effectively.
Clinical trials for novel retinoblastoma therapies are accessible at major South Korean tertiary hospitals. Academic centers like Severance Hospital and Samsung Medical Center conduct research on intra-arterial chemotherapy and intravitreal injections. These trials focus on eye salvage and reducing treatment side effects for pediatric patients.
Bookimed Expert Insight: Success in finding a trial slot in Korea often depends on clinic volume. Severance Hospital treats approximately 1.6 million outpatients annually and holds JCI accreditation. This massive patient flow typically correlates with more active research protocols compared to smaller centers. If a specific trial is full, these large academic institutions often have established networks to refer patients to international study sites quickly.
Patient Consensus: Families note that while Korea has advanced hospitals, trial windows for rare pediatric cancers are often very narrow. They advise asking tertiary children's hospitals directly about compassionate use or international referral options if local slots are closed.